DE1152785B - Diagnosticum - Google Patents
DiagnosticumInfo
- Publication number
- DE1152785B DE1152785B DEC17679A DEC0017679A DE1152785B DE 1152785 B DE1152785 B DE 1152785B DE C17679 A DEC17679 A DE C17679A DE C0017679 A DEC0017679 A DE C0017679A DE 1152785 B DE1152785 B DE 1152785B
- Authority
- DE
- Germany
- Prior art keywords
- urine
- dye
- test
- dragees
- caffeine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000002700 urine Anatomy 0.000 claims description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- QPFYXYFORQJZEC-UHFFFAOYSA-N phenazopyridine Chemical compound NC1=NC(N)=CC=C1N=NC1=CC=CC=C1 QPFYXYFORQJZEC-UHFFFAOYSA-N 0.000 claims description 8
- 229920002494 Zein Polymers 0.000 claims description 7
- 239000005019 zein Substances 0.000 claims description 7
- 229940093612 zein Drugs 0.000 claims description 7
- 210000002784 stomach Anatomy 0.000 claims description 6
- 210000004211 gastric acid Anatomy 0.000 claims description 4
- 230000002496 gastric effect Effects 0.000 claims description 3
- 230000002378 acidificating effect Effects 0.000 claims description 2
- 238000004040 coloring Methods 0.000 claims description 2
- 230000037406 food intake Effects 0.000 claims description 2
- 210000004051 gastric juice Anatomy 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims 8
- 239000008298 dragée Substances 0.000 claims 6
- 239000000975 dye Substances 0.000 claims 6
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims 4
- 229960001948 caffeine Drugs 0.000 claims 4
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 4
- 239000004310 lactic acid Substances 0.000 claims 2
- 235000014655 lactic acid Nutrition 0.000 claims 2
- 210000003932 urinary bladder Anatomy 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- 239000009173 Normacid Substances 0.000 claims 1
- 208000004880 Polyuria Diseases 0.000 claims 1
- 239000000987 azo dye Substances 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 238000002845 discoloration Methods 0.000 claims 1
- 230000035619 diuresis Effects 0.000 claims 1
- 230000000763 evoking effect Effects 0.000 claims 1
- 239000011521 glass Substances 0.000 claims 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hcl hcl Chemical compound Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 claims 1
- 239000002207 metabolite Substances 0.000 claims 1
- 239000000049 pigment Substances 0.000 claims 1
- VHNQIURBCCNWDN-UHFFFAOYSA-N pyridine-2,6-diamine Chemical class NC1=CC=CC(N)=N1 VHNQIURBCCNWDN-UHFFFAOYSA-N 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 230000028327 secretion Effects 0.000 claims 1
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 6
- 229940039227 diagnostic agent Drugs 0.000 description 5
- 239000000032 diagnostic agent Substances 0.000 description 5
- 229960000948 quinine Drugs 0.000 description 4
- 235000001258 Cinchona calisaya Nutrition 0.000 description 3
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 3
- 241000416162 Astragalus gummifer Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- 241000978776 Senegalia senegal Species 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 235000010487 tragacanth Nutrition 0.000 description 2
- 239000000196 tragacanth Substances 0.000 description 2
- 229940116362 tragacanth Drugs 0.000 description 2
- CRMACCRNCSJWTO-UHFFFAOYSA-N 2h-pyridine-1,2-diamine Chemical compound NC1C=CC=CN1N CRMACCRNCSJWTO-UHFFFAOYSA-N 0.000 description 1
- RMMXTBMQSGEXHJ-UHFFFAOYSA-N Aminophenazone Chemical compound O=C1C(N(C)C)=C(C)N(C)N1C1=CC=CC=C1 RMMXTBMQSGEXHJ-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229960000212 aminophenazone Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 229940125722 laxative agent Drugs 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229940124641 pain reliever Drugs 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N31/00—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
- G01N31/22—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators
- G01N31/221—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators for investigating pH value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C1/00—Photosensitive materials
- G03C1/005—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein
- G03C1/04—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein with macromolecular additives; with layer-forming substances
- G03C1/047—Proteins, e.g. gelatine derivatives; Hydrolysis or extraction products of proteins
- G03C2001/0471—Isoelectric point of gelatine
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Inorganic Chemistry (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Surgery (AREA)
- Medical Informatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH850426X | 1957-11-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1152785B true DE1152785B (de) | 1963-08-14 |
Family
ID=4542247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DEC17679A Pending DE1152785B (de) | 1957-11-05 | 1958-10-16 | Diagnosticum |
Country Status (6)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3309274A (en) * | 1962-07-23 | 1967-03-14 | Brilliant Herbert | Use of fluorescent dyes in dental diagnostic methods |
| US3236601A (en) * | 1964-11-04 | 1966-02-22 | Miles Lab | Method of detecting unconjugated catechol amine metabolites |
| US4056609A (en) * | 1976-01-28 | 1977-11-01 | Gunn, Kirchubel & Miller | Article for diagnosis of achlorhydria |
| US4128399A (en) * | 1976-03-15 | 1978-12-05 | Liotta Lance A | Device and method for detecting phenothiazine-type drugs in urine |
| WO2007007100A2 (en) * | 2005-07-12 | 2007-01-18 | The Leeds Teaching Hospitals Nhs Trust | Measurement of gastric acid secretion |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2791533A (en) * | 1951-02-24 | 1957-05-07 | Security Trust Company | Ion exchange resin indicator compound |
| GB760403A (en) * | 1952-10-16 | 1956-10-31 | Abbott Lab | Improvements in or relating to enteric coatings |
| GB779303A (en) * | 1955-04-12 | 1957-07-17 | Miles Lab | Diagnostic reagent |
| FR1122988A (fr) * | 1955-04-25 | 1956-09-14 | Miles Lab | Réactif pour diagnostic |
| US2794786A (en) * | 1955-05-27 | 1957-06-04 | Security Trust Company | Thionin dye-ion exchange resin indicator compounds |
-
0
- BE BE572457D patent/BE572457A/xx unknown
- NL NL101676D patent/NL101676C/xx active
-
1957
- 1957-11-05 CH CH358603D patent/CH358603A/de unknown
-
1958
- 1958-10-16 DE DEC17679A patent/DE1152785B/de active Pending
- 1958-10-28 GB GB34524/58A patent/GB850426A/en not_active Expired
- 1958-11-04 US US771725A patent/US2992166A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| NL101676C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | |
| CH358603A (de) | 1961-11-30 |
| GB850426A (en) | 1960-10-05 |
| BE572457A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | |
| US2992166A (en) | 1961-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2950463A1 (de) | Gallensaeuren enthaltende pharmazeutische zubereitung mit verlaengerter wirkungsdauer | |
| DE60108154T2 (de) | Pharmazeutische Zubereitungen enthaltend Clavulansäure | |
| DE2217132A1 (de) | Festes, oral einzunehmendes Arznei mittel | |
| AT389226B (de) | Verfahren zur herstellung einer analgetischen und antiinflammatorischen pharmazeutischen zubereitung | |
| CH647409A5 (de) | Pharmazeutische zubereitung zur behandlung und verhinderung von entzuendlichen darmkrankheiten, salze der 5,5'-azobissalicylsaeure und verfahren zur herstellung dieser salze. | |
| DE1152785B (de) | Diagnosticum | |
| DE69919963T2 (de) | Magnesiumoxid enthaltendes Abführmittel | |
| AT209004B (de) | Diagnosticum | |
| EP0652762B1 (de) | Neuartiges anxiolytikum | |
| DE2163538B2 (de) | Verfahren zur Herstellung wäßriger Suspensionen von Chloramphenicol-palmitat | |
| DE1908804A1 (de) | Radioaktive Verbindungen zur Bestimmung der Fettresorption | |
| DE3117756C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| DE2147066C3 (de) | Verfahren und Schnelltest-Tablette zur orientierenden selektiven Schnellbestimmung von Calcium Im Harn | |
| DE1492055B1 (de) | Neue Zubereitungsform des N-(5-Nitrofurfuryliden)-1-aminohydantoins | |
| DE3632791A1 (de) | Mittel gegen altersbedingte veraenderungen | |
| DE3511862C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| DE2157201A1 (de) | Verbesserte orale applikationsform von raubasin | |
| DE1933118A1 (de) | Geraet und Verfahren zur in-vitro-Untersuchung des Aufloeseverhaltens von Arzneistoffen im Gastrointestinaltrakt | |
| DE2015877B2 (de) | Arzneimittel zur Behandlung der Prostatahypertrophie | |
| WO1984001502A1 (en) | Contraceptive vaginal tablets and manufacturing method thereof | |
| CH620124A5 (en) | Magnesium chloride tablets and process for their production | |
| AT282055B (de) | Verfahren zur Herstellung neuer Valepotriate | |
| DE2839311C2 (de) | Pharmazeutisches Präparat gegen Geschwüre | |
| DE407895C (de) | Verfahren zur Herstellung elastischer Arzneitabletten | |
| DE2138577A1 (de) | Pharmazeutische Zubereitung |